Securities code: Hunan Warrant Pharmaceutical Co.Ltd(688799) securities abbreviation: Hunan Warrant Pharmaceutical Co.Ltd(688799) Announcement No.: 2022010 Hunan Warrant Pharmaceutical Co.Ltd(688799)
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and completeness of its contents in accordance with the law.
Hunan Warrant Pharmaceutical Co.Ltd(688799) (hereinafter referred to as “the company”) convened the third meeting of the third board of directors of the company on March 26, 2022, deliberated and adopted the proposal on by election of independent directors of the third board of directors of the company and the proposal on adjusting the members of the special committee of the board of directors of the company. The relevant information is hereby announced as follows:
Mr. Peng Tong, an independent director of the company, has served as an independent director of the company since March 2016, and his term of office expires in 6 years. According to the rules for independent directors of listed companies, the term of re-election of independent directors of listed companies shall not exceed six years. Therefore, Mr. Peng Tong voluntarily applied to resign from the corresponding positions of the company’s independent director and the special committee of the board of directors (convener of the nomination committee, member of the remuneration and assessment committee and member of the audit committee). After his resignation, he will no longer hold any position in the company. Mr. Peng Tong’s departure will result in less than one-third of the number of independent directors of the company. In order to ensure the normal operation of the board of directors and the normal production and operation of the company, Mr. Peng Tong will continue to perform his duties in accordance with relevant laws, regulations and the Hunan Warrant Pharmaceutical Co.Ltd(688799) articles of Association (hereinafter referred to as the “articles of association”) before the election of new independent directors.
In order to ensure the normal operation of the board of directors of the company, in accordance with the company law, the securities law, the Listing Rules of the science and Innovation Board of Shanghai Stock Exchange and other relevant laws and regulations and the articles of association, after the nomination committee of the board of directors reviewed the qualifications of the recommended candidates, the board of directors of the company nominated Mr. Zhang Peng as the candidate for independent director of the third board of directors of the company. See the attachment for Mr. Zhang Peng’s resume.
Mr. Zhang Peng is not allowed to serve as a director as stipulated in the company law and the articles of association, nor is he determined by the CSRC to be a prohibited person in the market and is still in the period of prohibition. He meets the qualifications stipulated in the company law, the Listing Rules of science and innovation board of Shanghai Stock Exchange and other relevant laws and regulations and the articles of association.
Mr. Zhang Peng has not obtained the qualification certificate of independent director. He promises to participate in the latest independent director qualification training held by Shanghai Stock Exchange and obtain the qualification certificate of independent director after this nomination.
If Mr. Zhang Peng is elected as an independent director of the company through the deliberation of the general meeting of shareholders, Mr. Zhang Peng will also serve as the corresponding position of Mr. Peng Tong in the special committee of the board of directors (convener of the nomination committee, member of the remuneration and assessment committee and member of the Audit Committee), and his term of office will be the same as that of the third board of directors of the company.
It is hereby announced.
Attachment: resume of independent director candidates
Hunan Warrant Pharmaceutical Co.Ltd(688799) board of directors March 29, 2022 Annex: resume of independent director candidates
Mr. Zhang Peng, born in 1976, Chinese nationality, without permanent residency abroad, graduated from the University of Kentucky with a doctorate degree. From September 2008 to March 2012, served as senior director of protein science of Sino US Guanke Biotechnology Co., Ltd; From April 2012 to now, he has served as the senior vice president of Zhongshan kangfang biomedical Co., Ltd.
